Biochemical Reagent
-
BA5264 AtogepantSummary: Atogepant (MK-8031) is an orally effective and selective antagonist. - BA5265 CagrilintideSummary: Cagrilintide is a novel long-acting acylated glucagon analog under investigation as a non-selective agonist of the amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR).
- BA5266 VazegepantSummary: Vazegepant (Zavegepant) is an orally effective calcitonin gene-related peptide receptor antagonist with potential for acute studies in migraine.
- BA5267 ChemR23-IN-1Summary: ChemR23-IN-1 is an inhibitor at 38 nM and 100 nM for human and mouse, respectively.
- BA5268 PentagastrinSummary: Pentagastrin (ICI-50123) is a potent and selective cholecystokinin B receptor antagonist.
- BA5269 DevazepideSummary: Devazepide (L-364,718) is a potent, competitive, selective, orally available, nonpeptide cholecystokinin receptor antagonist with values of 81pM, 45pM and 245nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively.
- BA5271 SograzepideSummary: Sograzepide (Netazepide; YF476; YM-220) is a very potent, highly selective and orally active antagonist.
- BA5272 TetragastrinSummary: Tetragastrin (Cholecystokinintetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin that stimulates gastric juice secretion.
- BA5273 ProglumideSummary: Proglumide is a non-peptide and orally active cholecystokinin receptor antagonist.
- BA5274 NastorazepideSummary: Nastorazepide (Z-360) is a selective, orally potent, 1,5-benzodiazepine derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist.